The invention relates to substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-ones, in particular for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and therapy of neoplastic disorders.
本发明涉及取代的3-(
联苯基-3-基)-
4-羟基-8-甲氧基-1-氮杂螺[4.5]癸-3-烯-2-酮,特别是用于治疗目的,药物组合物及其在治疗中的应用,特别是用于预防和治疗肿瘤性疾病。